Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: The crosstalk between immune cells and tumor pyroptosis: advancing cancer immunotherapy strategies

Fig. 3

Molecular mechanisms of T cells and NK cells on pyroptosis. CD8+T cells and NK cells induce cancer cell pyroptosis by secreting GzmA and GzmB, which are enzymes capable of cleaving GSDMB and GSDME, respectively. In addition, activated cytotoxic lymphocytes release IFN-γ, upregulating GSDMB expression in cancer cells. Activated NK cells release TNF-α, increasing the expression of endogenous GSDMB and promoting pyroptosis induced by GzmA. IL-17A, a pro-inflammatory cytokine, mainly secreted by γδT cells in the immune microenvironment of colorectal tumours, could promote intracellular ROS accumulation by inducing mitochondrial dysfunction. Furthermore, IL-17A could induce pyroptosis of colorectal cancer cells and significantly upregulate the secretion of inflammatory factors

Back to article page